Interferon (IFN)-γ-inducible protein-10 : Association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-α2a and ribavirin for chronic hepatitis C virus infection
- Author
- ROMERO, Ana I1 ; LAGGING, Martin1 2 ; SCHALM, Solko W9 ; ZEUZEM, Stefan10 ; NEGRO, Francesco11 ; VERHEIJ-HART, Elke9 ; HELLSTRAND, Kristoffer1 ; WESTIN, Johan2 ; DHILLON, Amar P3 ; DUSTIN, Lynn B4 ; PAWLOTSKY, Jean-Michel5 ; NEUMANN, Avidan U6 ; FERRARI, Carlo7 ; MISSALE, Gabriele7 ; HAAGMANS, Bart L8
[1] Department of Virology, University of Göteborg, Göteborg, Sweden
[2] Department of Infectious Diseases, University of Göteborg, Göteborg, Sweden
[3] Department of Histopathology, Royal Free Hospital, London, United Kingdom
[4] Center for the Study of Hepatitis C, Rockefeller University, New York, New York, United States
[5] Hôpital Henri Mondor- Université Paris XII, Créteil, France
[6] Bar-Ilan University, Ramat-Gan, Israel
[7] Azienda Ospedaliera di Parma, Parma, Italy
[8] Department of Virology, Erasmus MC, Netherlands
[9] University Hospital Rotterdam Dijkzigt, Rotterdam, Netherlands
[10] Saarland University Hospital, Homburg/Saar, Germany
[11] Hospital University of Geneva, Geneva, Switzerland
DITTO-HCV Study Group - Source
The Journal of infectious diseases. 2006, Vol 194, Num 7, pp 895-903, 9 p ; ref : 33 ref
- CODEN
- JIDIAQ
- ISSN
- 0022-1899
- Scientific domain
- Immunology, immunopathology, allergology; Microbiology, infectious diseases; Tropical medicine
- Publisher
- University of Chicago Press, Chicago, IL
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Antiviral Cinétique Hépatite virale C Infection Interféron gamma Microbiologie Pronostic Protéine Ribavirine Traitement Appareil digestif pathologie Cytokine Foie pathologie Virose
- Keyword (en)
- Antiviral Kinetics Viral hepatitis C Infection Gamma interferon Microbiology Prognosis Protein Ribavirin Treatment Digestive diseases Cytokine Hepatic disease Viral disease
- Keyword (es)
- Antiviral Cinética Hepatitis virica C Infección Interferón gamma Microbiología Pronóstico Proteína Ribavirina Tratamiento Aparato digestivo patología Citoquina Hígado patología Virosis
- Classification
- Pascal
- 002 Biological and medical sciences / 002A Fundamental and applied biological sciences. Psychology / 002A05 Microbiology
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B05 Infectious diseases / 002B05C Viral diseases / 002B05C02 Human viral diseases / 002B05C02G Viral hepatitis
- Discipline
- Infectious pathology Microbiology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 18139611
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1086/507307 
https://dx.doi.org/10.1086/507307
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:14:\"10.1086\/507307\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:204:\"Interferon (IFN)-\u03b3-inducible protein-10 : Association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-\u03b12a and ribavirin for chronic hepatitis C virus infection\";s:9:\"\u0000*\u0000jtitle\";s:34:\"The Journal of infectious diseases\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. infect. dis\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:3:\"194\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:3:\"895\";s:8:\"\u0000*\u0000epage\";s:3:\"903\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-1899\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"ROMERO\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Ana I\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:15:\"LAGGING, Martin\";i:1;s:15:\"SCHALM, Solko W\";i:2;s:14:\"ZEUZEM, Stefan\";i:3;s:16:\"NEGRO, Francesco\";i:4;s:18:\"VERHEIJ-HART, Elke\";i:5;s:22:\"HELLSTRAND, Kristoffer\";i:6;s:13:\"WESTIN, Johan\";i:7;s:15:\"DHILLON, Amar P\";i:8;s:14:\"DUSTIN, Lynn B\";i:9;s:22:\"PAWLOTSKY, Jean-Michel\";i:10;s:17:\"NEUMANN, Avidan U\";i:11;s:14:\"FERRARI, Carlo\";i:12;s:17:\"MISSALE, Gabriele\";i:13;s:16:\"HAAGMANS, Bart L\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JIDIAQ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:204:\"Interferon (IFN)-\u03b3-inducible protein-10 : Association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-\u03b12a and ribavirin for chronic hepatitis C virus infection\";s:8:\"\u0000*\u0000place\";s:11:\"Chicago, IL\";s:6:\"\u0000*\u0000pub\";s:27:\"University of Chicago Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:14:\"10.1086\/507307\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:204:\"Interferon (IFN)-\u03b3-inducible protein-10 : Association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-\u03b12a and ribavirin for chronic hepatitis C virus infection\";s:9:\"\u0000*\u0000jtitle\";s:34:\"The Journal of infectious diseases\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. infect. dis\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:3:\"194\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:3:\"895\";s:8:\"\u0000*\u0000epage\";s:3:\"903\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-1899\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"ROMERO\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Ana I\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:15:\"LAGGING, Martin\";i:1;s:15:\"SCHALM, Solko W\";i:2;s:14:\"ZEUZEM, Stefan\";i:3;s:16:\"NEGRO, Francesco\";i:4;s:18:\"VERHEIJ-HART, Elke\";i:5;s:22:\"HELLSTRAND, Kristoffer\";i:6;s:13:\"WESTIN, Johan\";i:7;s:15:\"DHILLON, Amar P\";i:8;s:14:\"DUSTIN, Lynn B\";i:9;s:22:\"PAWLOTSKY, Jean-Michel\";i:10;s:17:\"NEUMANN, Avidan U\";i:11;s:14:\"FERRARI, Carlo\";i:12;s:17:\"MISSALE, Gabriele\";i:13;s:16:\"HAAGMANS, Bart L\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JIDIAQ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:204:\"Interferon (IFN)-\u03b3-inducible protein-10 : Association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-\u03b12a and ribavirin for chronic hepatitis C virus infection\";s:8:\"\u0000*\u0000place\";s:11:\"Chicago, IL\";s:6:\"\u0000*\u0000pub\";s:27:\"University of Chicago Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:14:\"10.1086\/507307\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:14:\"10.1086\/507307\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:204:\"Interferon (IFN)-\u03b3-inducible protein-10 : Association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-\u03b12a and ribavirin for chronic hepatitis C virus infection\";s:9:\"\u0000*\u0000jtitle\";s:34:\"The Journal of infectious diseases\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. infect. dis\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:3:\"194\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:3:\"895\";s:8:\"\u0000*\u0000epage\";s:3:\"903\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-1899\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"ROMERO\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Ana I\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:15:\"LAGGING, Martin\";i:1;s:15:\"SCHALM, Solko W\";i:2;s:14:\"ZEUZEM, Stefan\";i:3;s:16:\"NEGRO, Francesco\";i:4;s:18:\"VERHEIJ-HART, Elke\";i:5;s:22:\"HELLSTRAND, Kristoffer\";i:6;s:13:\"WESTIN, Johan\";i:7;s:15:\"DHILLON, Amar P\";i:8;s:14:\"DUSTIN, Lynn B\";i:9;s:22:\"PAWLOTSKY, Jean-Michel\";i:10;s:17:\"NEUMANN, Avidan U\";i:11;s:14:\"FERRARI, Carlo\";i:12;s:17:\"MISSALE, Gabriele\";i:13;s:16:\"HAAGMANS, Bart L\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JIDIAQ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:204:\"Interferon (IFN)-\u03b3-inducible protein-10 : Association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-\u03b12a and ribavirin for chronic hepatitis C virus infection\";s:8:\"\u0000*\u0000place\";s:11:\"Chicago, IL\";s:6:\"\u0000*\u0000pub\";s:27:\"University of Chicago Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:14:\"10.1086\/507307\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:204:\"Interferon (IFN)-\u03b3-inducible protein-10 : Association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-\u03b12a and ribavirin for chronic hepatitis C virus infection\";s:9:\"\u0000*\u0000jtitle\";s:34:\"The Journal of infectious diseases\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. infect. dis\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:3:\"194\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:3:\"895\";s:8:\"\u0000*\u0000epage\";s:3:\"903\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-1899\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"ROMERO\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Ana I\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:15:\"LAGGING, Martin\";i:1;s:15:\"SCHALM, Solko W\";i:2;s:14:\"ZEUZEM, Stefan\";i:3;s:16:\"NEGRO, Francesco\";i:4;s:18:\"VERHEIJ-HART, Elke\";i:5;s:22:\"HELLSTRAND, Kristoffer\";i:6;s:13:\"WESTIN, Johan\";i:7;s:15:\"DHILLON, Amar P\";i:8;s:14:\"DUSTIN, Lynn B\";i:9;s:22:\"PAWLOTSKY, Jean-Michel\";i:10;s:17:\"NEUMANN, Avidan U\";i:11;s:14:\"FERRARI, Carlo\";i:12;s:17:\"MISSALE, Gabriele\";i:13;s:16:\"HAAGMANS, Bart L\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JIDIAQ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:204:\"Interferon (IFN)-\u03b3-inducible protein-10 : Association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-\u03b12a and ribavirin for chronic hepatitis C virus infection\";s:8:\"\u0000*\u0000place\";s:11:\"Chicago, IL\";s:6:\"\u0000*\u0000pub\";s:27:\"University of Chicago Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:14:\"10.1086\/507307\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:204:\"Interferon (IFN)-\u03b3-inducible protein-10 : Association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-\u03b12a and ribavirin for chronic hepatitis C virus infection\";s:9:\"\u0000*\u0000jtitle\";s:34:\"The Journal of infectious diseases\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. infect. dis\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:3:\"194\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:3:\"895\";s:8:\"\u0000*\u0000epage\";s:3:\"903\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-1899\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"ROMERO\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Ana I\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:15:\"LAGGING, Martin\";i:1;s:15:\"SCHALM, Solko W\";i:2;s:14:\"ZEUZEM, Stefan\";i:3;s:16:\"NEGRO, Francesco\";i:4;s:18:\"VERHEIJ-HART, Elke\";i:5;s:22:\"HELLSTRAND, Kristoffer\";i:6;s:13:\"WESTIN, Johan\";i:7;s:15:\"DHILLON, Amar P\";i:8;s:14:\"DUSTIN, Lynn B\";i:9;s:22:\"PAWLOTSKY, Jean-Michel\";i:10;s:17:\"NEUMANN, Avidan U\";i:11;s:14:\"FERRARI, Carlo\";i:12;s:17:\"MISSALE, Gabriele\";i:13;s:16:\"HAAGMANS, Bart L\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JIDIAQ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:204:\"Interferon (IFN)-\u03b3-inducible protein-10 : Association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-\u03b12a and ribavirin for chronic hepatitis C virus infection\";s:8:\"\u0000*\u0000place\";s:11:\"Chicago, IL\";s:6:\"\u0000*\u0000pub\";s:27:\"University of Chicago Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
